202 related articles for article (PubMed ID: 37668485)
1. Euglycemic diabetic ketoacidosis in a patient on sodium-glucose cotransporter 2 inhibitors.
Hammond DB; Ingram CC
JAAPA; 2023 Sep; 36(9):1-3. PubMed ID: 37668485
[TBL] [Abstract][Full Text] [Related]
2. Euglycemic Diabetic Ketoacidosis Associated With SGLT2 Inhibitor Therapy: A Case Report.
Klinkner G; Steingraber-Pharr M
AACN Adv Crit Care; 2023 Mar; 34(1):27-32. PubMed ID: 36877649
[TBL] [Abstract][Full Text] [Related]
3. [Acidosis without marked hyperglycemia : Euglycemic diabetic ketoacidosis associated with SGLT2-Inhibitors].
Valek R; Von der Mark J
Med Klin Intensivmed Notfmed; 2017 Mar; 112(2):145-148. PubMed ID: 27221094
[TBL] [Abstract][Full Text] [Related]
4. Euglycemic Diabetic Ketoacidosis Associated With Sodium-Glucose Cotransporter-2 Inhibitors After Cardiac Surgery: A Review of Current Literature.
Branco A; Fatima R; Liblik K; Jackson R; Payne D; El-Diasty M
J Cardiothorac Vasc Anesth; 2022 Oct; 36(10):3877-3886. PubMed ID: 35863986
[TBL] [Abstract][Full Text] [Related]
5. [Diabetic euglycemic ketosis or ketoacidosis in individuals with type 2 diabetes treated by SGLT2 inhibitors: A series of Belgian clinical cases].
Menghoum N; Oriot P; Hermans MP; Mariage JL
Rev Med Interne; 2020 Apr; 41(4):226-231. PubMed ID: 31866073
[TBL] [Abstract][Full Text] [Related]
6. Sodium-glucose cotransporter-2 inhibitors: Understanding the mechanisms for therapeutic promise and persisting risks.
Perry RJ; Shulman GI
J Biol Chem; 2020 Oct; 295(42):14379-14390. PubMed ID: 32796035
[TBL] [Abstract][Full Text] [Related]
7. Intraoperative Diagnosis of Sodium-Glucose Cotransporter 2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis: A Case Report.
Seger CD; Xing H; Wang L; Shin JS
A A Pract; 2021 Jan; 15(1):e01380. PubMed ID: 33512907
[TBL] [Abstract][Full Text] [Related]
8. Sodium-Glucose Cotransporter-2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis After Orthotopic Heart Transplant in a Prediabetic Patient: A Case Report.
Cha BM; Davoudi R; DiVita MC; Fan AM; Kamath MY
Transplant Proc; 2021 Oct; 53(8):2636-2639. PubMed ID: 34531071
[TBL] [Abstract][Full Text] [Related]
9. Sodium-glucose cotransporter 2 inhibitor-induced euglycemic diabetic ketoacidosis in a patient with coronavirus disease 2019: a case report.
Yii ESS; Azli AW; Sitaram PN
J Med Case Rep; 2022 Jan; 16(1):17. PubMed ID: 34983625
[TBL] [Abstract][Full Text] [Related]
10. Ketoacidosis Due to Empagliflozin, a Paradigm Shift: Case Report and Review of Literature.
Hernandez-Quiles C; Ramirez-Duque N; Acosta-Delgado D
Curr Diabetes Rev; 2019; 15(4):259-262. PubMed ID: 30047331
[TBL] [Abstract][Full Text] [Related]
11. Sodium-glucose cotransporter-2-induced euglycemic diabetic ketoacidosis unmasks latent autoimmune diabetes in a patient misdiagnosed with type 2 diabetes mellitus: a case report.
Vadasz B; Arazi M; Shukha Y; Koren O; Taher R
J Med Case Rep; 2021 Feb; 15(1):62. PubMed ID: 33581735
[TBL] [Abstract][Full Text] [Related]
12. The effect of preoperative sodium-glucose cotransporter 2 inhibitors on the incidence of perioperative metabolic acidosis: A retrospective cohort study.
Iwasaki Y; Sasabuchi Y; Horikita S; Furukawa T; Shiotsuka J; Lefor AK; Sanui M
BMC Endocr Disord; 2022 Aug; 22(1):209. PubMed ID: 35987618
[TBL] [Abstract][Full Text] [Related]
13. [Perioperative Ketoacidosis under SGLT2-Inhibitors].
Buck S; Russo SG
Anasthesiol Intensivmed Notfallmed Schmerzther; 2021 Oct; 56(10):704-708. PubMed ID: 34704247
[TBL] [Abstract][Full Text] [Related]
14. Severe ketoacidosis in a patient taking an SGLT2 inhibitor for diabetes.
Hatlen KV; Sharma A; Nermoen I
Tidsskr Nor Laegeforen; 2020 Sep; 140(12):. PubMed ID: 32900172
[TBL] [Abstract][Full Text] [Related]
15. SGLT2 Inhibitors and Euglycemic Ketoacidosis.
Masuta P; Johri G; Paul M
Am J Ther; 2018; 25(4):e498-e500. PubMed ID: 28537992
[No Abstract] [Full Text] [Related]
16. The current role of sodium-glucose cotransporter 2 inhibitors in type 2 diabetes mellitus management.
Xu B; Li S; Kang B; Zhou J
Cardiovasc Diabetol; 2022 May; 21(1):83. PubMed ID: 35614469
[TBL] [Abstract][Full Text] [Related]
17. Sodium-Glucose Cotransporter-2 Inhibitors and Risk of Diabetic Ketoacidosis Among Adults With Type 2 Diabetes: A Systematic Review and Meta-Analysis.
Colacci M; Fralick J; Odutayo A; Fralick M
Can J Diabetes; 2022 Feb; 46(1):10-15.e2. PubMed ID: 34116926
[TBL] [Abstract][Full Text] [Related]
18. Euglycemic Diabetic Ketoacidosis Associated With Sodium-Glucose Cotransporter Type 2 Inhibitors in Patients With Type 2 Diabetes Mellitus Receiving Oral Therapy.
Dull RB; Spangler ML; Knezevich EL; Lau BM
J Pharm Pract; 2019 Apr; 32(2):240-243. PubMed ID: 29241389
[TBL] [Abstract][Full Text] [Related]
19. SGLT2 Inhibitors May Predispose to Ketoacidosis.
Taylor SI; Blau JE; Rother KI
J Clin Endocrinol Metab; 2015 Aug; 100(8):2849-52. PubMed ID: 26086329
[TBL] [Abstract][Full Text] [Related]
20. Potential Safety Issues with Use of Sodium-Glucose Cotransporter 2 Inhibitors, Particularly in People with Type 2 Diabetes and Chronic Kidney Disease.
Milder TY; Stocker SL; Day RO; Greenfield JR
Drug Saf; 2020 Dec; 43(12):1211-1221. PubMed ID: 33095409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
